Oncology - Gynecologic cancer Archives - Insights https://news.mayocliniclabs.com/category/oncology/oncology-gynecologic-cancer/ Get the latest news and education from Mayo Clinic Laboratories Wed, 30 Oct 2024 18:23:05 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer care https://news.mayocliniclabs.com/2024/10/28/dr-dong-chen-and-dr-sounak-gupta-join-beckers-healthcare-podcast-to-discuss-molecular-testing-in-cancer-care/ https://news.mayocliniclabs.com/2024/10/28/dr-dong-chen-and-dr-sounak-gupta-join-beckers-healthcare-podcast-to-discuss-molecular-testing-in-cancer-care/#respond Tue, 29 Oct 2024 01:00:00 +0000 https://news.mayocliniclabs.com/?p=113101 Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer careDr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the right molecular tests for patients, the impact of genetic testing on cancer diagnosis and treatment, and how Mayo Clinic Laboratories is helping physicians make informed decisions for the best patient outcomes.

The post Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer care appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/10/28/dr-dong-chen-and-dr-sounak-gupta-join-beckers-healthcare-podcast-to-discuss-molecular-testing-in-cancer-care/feed/ 0 Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. https://news.mayocliniclabs.com/2024/04/23/assay-identifies-patients-eligible-for-new-ovarian-cancer-drug-maryam-shahi-m-d/ https://news.mayocliniclabs.com/2024/04/23/assay-identifies-patients-eligible-for-new-ovarian-cancer-drug-maryam-shahi-m-d/#respond Tue, 23 Apr 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=109931 Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication.

The post Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/04/23/assay-identifies-patients-eligible-for-new-ovarian-cancer-drug-maryam-shahi-m-d/feed/ 0 Revolutionizing Endometrial Cancer Diagnostics https://news.mayocliniclabs.com/2023/12/20/revolutionizing-endometrial-cancer-diagnostics/ https://news.mayocliniclabs.com/2023/12/20/revolutionizing-endometrial-cancer-diagnostics/#respond Wed, 20 Dec 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=107095 Revolutionizing Endometrial Cancer DiagnosticsEndometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of Laboratory Medicine and Pathology consultants. Sounak Gupta, M.B.B.S., Ph.D., vice chair of Oncology Practice for the Division of Laboratory Genetics and Genomics; Maryam Shahi, M.D., senior consultant for Anatomic Pathology; and Andrea Mariani, M.D., M.S., division chair of Gynecologic Surgery, explore the critical significance of molecular profiling and collaborative efforts driving these innovations, highlighting Mayo Clinic’s revolutionary influence on patient care.

The post Revolutionizing Endometrial Cancer Diagnostics appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/12/20/revolutionizing-endometrial-cancer-diagnostics/feed/ 0 Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D. https://news.mayocliniclabs.com/2023/07/18/gynecological-ngs-panels-offer-cost-effective-cancer-testing-sounak-gupta-m-b-b-s-ph-d/ https://news.mayocliniclabs.com/2023/07/18/gynecological-ngs-panels-offer-cost-effective-cancer-testing-sounak-gupta-m-b-b-s-ph-d/#respond Tue, 18 Jul 2023 13:00:00 +0000 https://news.mayocliniclabs.com/?p=97926 Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' gynecological NGS panels provide focused assessments of gynecological cancers. The cost-effective tests fill the gap between single gene assays and large cancer panels, to inform prognosis and treatment.

The post Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/07/18/gynecological-ngs-panels-offer-cost-effective-cancer-testing-sounak-gupta-m-b-b-s-ph-d/feed/ 0